Literature DB >> 15949719

Towards a model to explain the intragenic complementation in the heteromultimeric protein propionyl-CoA carboxylase.

Pilar Rodríguez-Pombo1, Celia Pérez-Cerdá, Belén Pérez, Lourdes R Desviat, Luis Sánchez-Pulido, Magdalena Ugarte.   

Abstract

Mutations in the PCCA or PCCB genes coding for alpha and beta subunits of propionyl CoA carboxylase can cause propionic acidemia. To understand the molecular basis of the intragenic complementation previously reported at the PCCB locus, we now examine the complementation behaviour of four carboxy-terminal and 11 amino-terminal naturally occurring mutant alleles both using cell fusion and reconstructing the complementation event by transfecting the mutant cDNAs to generate multimeric hybrid proteins. Alleles carrying mutations p.R410W and p.W531X are able to complement with 10 out of 11 amino-terminal mutations assayed. Only the unstable p.R512C, p.L519P and p.G112D mutants fail to complement. The results analyzed in the framework of the crystal structure of the homologous 12S transcarboxylase from Propionibacterium shermanii show that all mutant alleles studied are located at beta subunits interfaces, complementing alleles at the inter-trimer interface, where the catalysis probably happens, and non-complementing alleles at the intra-trimer interface, probably disrupting the trimer formation. Our results also show a remarkable stabilization effect when p.R410W is cotransfected with p.G246V. We propose a model for intragenic complementation requiring the production of two different beta subunits carrying carboxy and amino-terminal mutations that allow regenerating functional active sites and in which a stabilization effect between subunits could be relevant to ameliorate the biochemical phenotype of each mutation separately.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15949719     DOI: 10.1016/j.bbadis.2004.10.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Mild SMN missense alleles are only functional in the presence of SMN2 in mammals.

Authors:  Chitra C Iyer; Kaitlyn M Corlett; Aurélie Massoni-Laporte; Sandra I Duque; Narasimhan Madabusi; Sarah Tisdale; Vicki L McGovern; Thanh T Le; Phillip G Zaworski; W David Arnold; Livio Pellizzoni; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2018-10-01       Impact factor: 6.150

2.  Intragenic complementation of amino and carboxy terminal SMN missense mutations can rescue Smn null mice.

Authors:  Vicki L McGovern; Kaitlyn M Kray; W David Arnold; Sandra I Duque; Chitra C Iyer; Aurélie Massoni-Laporte; Eileen Workman; Aalapi Patel; Daniel J Battle; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2020-11-01       Impact factor: 6.150

Review 3.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

4.  A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice.

Authors:  Eileen Workman; Luciano Saieva; Tessa L Carrel; Thomas O Crawford; Don Liu; Cathleen Lutz; Christine E Beattie; Livio Pellizzoni; Arthur H M Burghes
Journal:  Hum Mol Genet       Date:  2009-03-27       Impact factor: 6.150

Review 5.  Structure and function of biotin-dependent carboxylases.

Authors:  Liang Tong
Journal:  Cell Mol Life Sci       Date:  2012-08-07       Impact factor: 9.261

Review 6.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

7.  Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase.

Authors:  Christine S Huang; Kianoush Sadre-Bazzaz; Yang Shen; Binbin Deng; Z Hong Zhou; Liang Tong
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

8.  Towards the development of an enzyme replacement therapy for the metabolic disorder propionic acidemia.

Authors:  Mahnaz Darvish-Damavandi; Han Kiat Ho; Tse Siang Kang
Journal:  Mol Genet Metab Rep       Date:  2016-07-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.